Global Biobank Management Systems Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biobank Management Systems Market Research Report 2024
Biobank Management System is a sample library resource management system based on cell sample workflow. According to the operations involved in the laboratory sample workflow, the entire process recording of the sample life cycle and efficient and continuous management of all-round quality control are achieved.
According to MRAResearch’s new survey, global Biobank Management Systems market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biobank Management Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Agilent Technologies
Autoscribe Informatics
DiData
AgileBio
CloudLIMS
Modul-Bio
TD Biobank
OpenSpecimen
Information Management Services
Azenta
BBMS
LabKey
FreeLIMS
LabWare
Titian
Octalsoft
Interactive Software
eLabNext
SoftSystem
STARLIMS
NEST
Origincell
Improve Medical
Segment by Type
Cloud
On-Premises
Medical
Pharmaceutical
Laboratory
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biobank Management Systems report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Biobank Management Systems market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biobank Management Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Agilent Technologies
Autoscribe Informatics
DiData
AgileBio
CloudLIMS
Modul-Bio
TD Biobank
OpenSpecimen
Information Management Services
Azenta
BBMS
LabKey
FreeLIMS
LabWare
Titian
Octalsoft
Interactive Software
eLabNext
SoftSystem
STARLIMS
NEST
Origincell
Improve Medical
Segment by Type
Cloud
On-Premises
Segment by Application
Medical
Pharmaceutical
Laboratory
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biobank Management Systems report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source